IFNA1 and systemic lupus erythematosus: SLE patients with a positive type I IFN signature have increased renal involvement and elevated anti-dsDNA Ab levels [46], and when both type I and II IFN signatures are present, they are associated with disease activity, flares, and disease injury in the kidney, skin, and nervous system [44,47].